Respective efficacy of gonadotrophins should be the heart of the debate.
Recombinant gonadotrophins offer future advances in reproductive medicine. It is questionable whether they produce more pregnancies than urinary gonadotrophins. No doubt future advances will permit this goal, but this has not yet been attained.
Emperaire
J C
JC
IVF Centre IFRAERES Aquitaine Santé Clinique, Maryse Bastié, Bordeaux-Bruges, France. jc.emperaire@aquitainesante.fr
D005260:Female; D005300:Fertility Agents, Female / Q000592:standards / Q000627:therapeutic use*; D006062:Gonadotropins / Q000235:genetics / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D010062:Ovulation Induction / Q000379:methods / Q000592:standards*; D011994:Recombinant Proteins / Q000627:therapeutic use
D005300:Fertility Agents, Female; D006062:Gonadotropins; D011994:Recombinant Proteins